Summary
This article discusses two analyses from the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes study [RECORD; NCT00379769; Home PD et al. Lancet 2009] of cardiovascular outcomes in patients who were treated with rosiglitazone.
- Diabetes Mellitus
- Diabetes & Endocrinology Clinical Trials Clinical Trials
- © 2009 MD Conference Express